Literature DB >> 20822996

Two cases with pulmonary mucosa-associated lymphoid tissue lymphoma successfully treated with clarithromycin.

Yuji Ishimatsu1, Hiroshi Mukae, Kiyoshi Matsumoto, Tatsuhiko Harada, Atsuko Hara, Shintaro Hara, Misato Amenomori, Hanako Fujita, Noriho Sakamoto, Tomayoshi Hayashi, Shigeru Kohno.   

Abstract

A 70-year-old woman with a history of sinobronchial syndrome was admitted to the hospital because of a cough, sputum, and abnormal chest shadow. She was diagnosed with pulmonary mucosa-associated lymphoid tissue lymphoma (p-MALToma) based on results of a pathologic examination and the gene rearrangements in the Ig heavy chain on Southern blot hybridization. Although p-MALToma did not regress with conventional therapy, it was reduced after long-term treatment with clarithromycin (CAM) (200 mg/d). A 57-year-old woman with a history of Sjögren syndrome and lymphocytic interstitial pneumonia had a mass lesion in the left lower lung field. CT image-guided biopsy established a diagnosis of p-MALToma. The p-MALToma regressed with long-term treatment with CAM (200 mg/d), whereas Helicobacter pylori (HP) eradication therapy was not effective in concurrent atrophic gastritis with HP. It is suggested that CAM, a macrolide antibiotic, may be effective in some patients with p-MALToma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20822996     DOI: 10.1378/chest.09-2358

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  13 in total

1.  Possible clinical effects of macrolides on the treatment of primary pulmonary mucosa-associated lymphoid tissue lymphoma.

Authors:  Kazuhiro Yatera; Yuji Ishimatsu; Noriho Sakamoto; Hiroshi Mukae
Journal:  Int J Hematol       Date:  2015-11-21       Impact factor: 2.490

2.  A case of follicular B-cell lymphoma treated using clarithromycin.

Authors:  Masashi Ohe; Satoshi Hashino
Journal:  Korean J Hematol       Date:  2011-09-30

3.  [Clarithromycin for monotherapy of B-cell MALT lymphoma?].

Authors:  C Auw-Hädrich; J Finke; A Serr; H Mittelviefhaus; C Bogdan; T Reinhard
Journal:  Ophthalmologe       Date:  2013-11       Impact factor: 1.059

Review 4.  Recent developments in nongastric mucosa-associated lymphoid tissue lymphoma.

Authors:  Marlene Troch; Barbara Kiesewetter; Markus Raderer
Journal:  Curr Hematol Malig Rep       Date:  2011-12       Impact factor: 3.952

5.  Successful treatment of recurrent follicular B-cell lymphoma with clarithromycin, prednisolone, and cyclophosphamide.

Authors:  Masashi Ohe; Satoshi Hashino
Journal:  Korean J Intern Med       Date:  2013-05-01       Impact factor: 2.884

6.  Imaging manifestations of autoimmune disease-associated lymphoproliferative disorders of the lung.

Authors:  Geewon Lee; Ho Yun Lee; Kyung Soo Lee; Kyung Jong Lee; Hoon-Suk Cha; Joungho Han; Man Pyo Chung
Journal:  Clin Rheumatol       Date:  2013-06-02       Impact factor: 2.980

7.  Immunology of fibrotic lung disease: managing infections whilst preventing autoimmunity?

Authors:  Thomas Hügle
Journal:  J Inflamm Res       Date:  2011-02-04

8.  Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent.

Authors:  An Mt Van Nuffel; Vidula Sukhatme; Pan Pantziarka; Lydie Meheus; Vikas P Sukhatme; Gauthier Bouche
Journal:  Ecancermedicalscience       Date:  2015-02-24

9.  An Unusual Presentation of Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma as Diffuse Pulmonary Infiltrates with Spontaneous Regression.

Authors:  Hye Seon Kang; Hea Yon Lee; Seung Joon Kim; Seok Chan Kim; Young Kyoon Kim; Gyeong Sin Park; Kyo Young Lee; Jung Im Jung; Ji Young Kang
Journal:  Cancer Res Treat       Date:  2014-09-15       Impact factor: 4.679

10.  Successful treatment of diffuse large B-cell lymphoma with clarithromycin and prednisolone.

Authors:  Masashi Ohe; Satoshi Hashino; Atsuo Hattori
Journal:  Korean J Hematol       Date:  2012-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.